S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.05%) $0.791
USD/RUB
(0.86%) $85.73

Echtzeitaktualisierungen für Opthea Ltd [OPT.AX]

Börse: ASX Industrie: Pharmaceuticals, Biotechnology & Life Sciences
Zuletzt aktualisiert28 Jun 2024 @ 08:10

-2.78% $ 0.350

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 08:10):
Our systems believe the stock currently is undervalued by 1.40% compare to its pairs and should correct upwards.

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage...

Stats
Tagesvolumen 2.62M
Durchschnittsvolumen 1.36M
Marktkapitalisierung 422.13M
EPS $-0.250 ( Q2 | 2023-12-31 )
Nächstes Ertragsdatum ( $0 ) 2024-08-28
Last Dividend $0.111 ( 2004-10-11 )
Next Dividend $0 ( N/A )
P/E -0.830
(Sector) 0
(Industry) 0
ATR14 $0.00200 (0.56%)
ACW.AX 34.78%
ADO.AX 0.00%
AGH.AX -4.17%
ANP.AX -4.92%
ATH.AX 0.00%
AVE.AX 0.00%
BIT.AX 2.70%
BNO.AX -10.00%
BOT.AX -5.48%
CAN.AX 0.00%
CPH.AX 0.00%
CSL.AX 0.02%
CTE.AX 8.77%
CUV.AX 0.85%
CYP.AX 1.72%
DXB.AX 0.00%
ECS.AX 0.00%
EOF.AX -6.25%
GSS.AX 1.41%
IDT.AX 0.00%
IMC.AX 0.00%
IMM.AX -11.94%
IMU.AX 5.56%
IXC.AX -10.45%
KZA.AX 9.59%
LCT.AX 7.14%
LGP.AX -9.52%
MSB.AX 1.02%
MVP.AX -1.22%
MXC.AX 2.44%
NEU.AX 3.15%
NOX.AX -2.94%
NSB.AX 2.56%
OCC.AX 0.00%
OPT.AX -2.78%
OSL.AX 0.00%
PAA.AX 0.00%
PAB.AX 0.00%
PAR.AX -1.92%
PBP.AX 0.00%
PIQ.AX -2.22%
PTX.AX -2.56%
PXS.AX 3.70%
PYC.AX 0.00%
RAC.AX 1.11%
RCE.AX 5.26%
SPL.AX 9.20%
TLX.AX 1.36%
VBS.AX 0.00%
Korrelation (AI algo v.1.1b): Undervalued: 1.40% $0.360 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

Volumen Korrelation

Lang: 0.02 (neutral)
Kurz: 0.84 (strong)
Signal:(51.155) Same movement expected

Opthea Ltd Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Opthea Ltd Korrelation - Währung/Rohstoff

The country flag -0.09
( neutral )
The country flag 0.10
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.16
( neutral )

Opthea Ltd Finanzdaten

Annual 2023
Umsatz: $161 163
Bruttogewinn: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2023
Umsatz: $161 163
Bruttogewinn: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2022
Umsatz: $125 047
Bruttogewinn: $-107 422 (-85.91 %)
EPS: $-0.340
FY 2021
Umsatz: $68 613.00
Bruttogewinn: $0.00 (0.00 %)
EPS: $-0.195

Financial Reports:

No articles found.

Opthea Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Opthea Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.111 2004-10-11
Last Dividend $0.111 2004-10-11
Next Dividend $0 N/A
Payout Date 2004-11-01
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.111 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-06-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2004 $0.111 5.43%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
11 Oct 2004 $0.111 25 Aug 2004 15 Oct 2004 01 Nov 2004

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
EZL.AX Dividend Royal 2024-02-02 Semi-Annually 24 11.64% 8.24
GRR.AX Dividend Royal 2024-03-12 Semi-Annually 14 11.88% 7.99
RKN.AX Dividend Royal 2023-08-31 Annually 22 15.73% 7.24
TWR.AX Dividend King 2024-06-12 Annually 25 5.98% 7.21
YAL.AX Dividend Royal 2024-03-12 Annually 7 12.76% 7.18
SHM.AX Dividend Royal 2024-03-14 Semi-Annually 9 14.97% 7.14
HZN.AX Dividend Royal 2024-04-18 Semi-Annually 4 18.99% 7.06
BHP.AX Dividend Royal 2024-03-07 Semi-Annually 37 6.46% 6.97
CDD.AX Ex Dividend King 2024-05-24 Annually 21 91.43% 6.79
KSL.AX Dividend Royal 2024-03-05 Semi-Annually 9 9.58% 6.77

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1 383.771.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.4671.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM8.771.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM5.100.80010.008.00[1 - 3]
quickRatioTTM5.000.80010.008.00[0.8 - 2.5]
cashRatioTTM4.821.50010.0010.00[0.2 - 2]
debtRatioTTM0.000780-1.5009.99-10.00[0 - 0.6]
interestCoverageTTM-8.081.000-4.10-4.10[3 - 30]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
freeCashFlowPerShareTTM-0.3062.00-0.153-0.306[0 - 20]
debtEquityRatioTTM-0.00277-1.500-0.01110.0166[0 - 2.5]
grossProfitMarginTTM-0.1691.000-6.15-6.15[0.2 - 0.8]
operatingProfitMarginTTM-1 413.431.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1 397.121.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.001060.800-3.33-2.66[0.5 - 2]
Total Score-0.994

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.5791.000-0.1590[1 - 100]
returnOnEquityTTM8.772.5010.0010.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.3062.00-0.102-0.306[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.06071.500-3.740[0.5 - 2]
operatingCashFlowSalesRatioTTM-1 027.631.000-10.000[0.1 - 0.5]
Total Score-0.617

Opthea Ltd Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Opthea Ltd

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.

Total Execution Time: 1.807708978653 seconds
Number of API calls: 3
Number of DB calls: 9